CA2001898A1 - Inhibition de retrovirus humains - Google Patents

Inhibition de retrovirus humains

Info

Publication number
CA2001898A1
CA2001898A1 CA 2001898 CA2001898A CA2001898A1 CA 2001898 A1 CA2001898 A1 CA 2001898A1 CA 2001898 CA2001898 CA 2001898 CA 2001898 A CA2001898 A CA 2001898A CA 2001898 A1 CA2001898 A1 CA 2001898A1
Authority
CA
Canada
Prior art keywords
acid
ellagitannin
hiv
tannin
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2001898
Other languages
English (en)
Inventor
Kuo-Hsiung Lee
Robert E. Kilkuskie
Gen-Ichiro Nonaka
Yung-Chi Cheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2001898A1 publication Critical patent/CA2001898A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2001898 1988-10-31 1989-10-31 Inhibition de retrovirus humains Abandoned CA2001898A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26455888A 1988-10-31 1988-10-31
US07/264,558 1988-10-31

Publications (1)

Publication Number Publication Date
CA2001898A1 true CA2001898A1 (fr) 1990-04-30

Family

ID=23006605

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2001898 Abandoned CA2001898A1 (fr) 1988-10-31 1989-10-31 Inhibition de retrovirus humains

Country Status (2)

Country Link
CA (1) CA2001898A1 (fr)
WO (1) WO1990004968A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7288273B1 (en) 2000-11-17 2007-10-30 The Penn State Research Foundation Gallotannins and ellagitannins as regulators of cytokine release

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03206044A (ja) * 1990-01-09 1991-09-09 Tsumura & Co 抗レトロウイルス剤
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
DE4106026A1 (de) * 1991-02-26 1992-08-27 Plantamed Arzneimittel Gmbh Pharmazeutische zubereitungen enthaltend eine gallussaeureverbindung und/oder quercetin sowie verfahren zur isolierung dieser verbindungen
DE4120296A1 (de) * 1991-06-28 1992-03-19 Regina Tilgner Rein pflanzliches kombinationspraeparat - gegen aids
DE4316347C1 (de) * 1993-02-26 1994-08-18 Ina Dr Levi Verfahren zur Herstellung einer pharmazeutischen Zubereitung und Verwendung derselben zur Behandlung bestimmter Erkrankungen
AU6037494A (en) * 1993-02-26 1994-09-14 Ina Levi Use of active substances in the therapy of certain diseases, process for preparing a pharmaceutical composition for that purpose and pharmaceutical compositions thus prepared
US5612341A (en) * 1995-06-07 1997-03-18 Biotech Research Laboratories Brominated hexahydroxybiphenyl derivatives
KR19980074710A (ko) * 1997-03-21 1998-11-05 손경식 콜레스테롤 저하 약제 조성물
US6043276A (en) * 1998-06-25 2000-03-28 Georgetown University School Of Medicine Compounds obtained from salvia species having antiviral activity
JP4521894B2 (ja) * 1999-05-28 2010-08-11 明治乳業株式会社 マトリックスメタロプロテアーゼ阻害剤
WO2001036436A1 (fr) * 1999-11-19 2001-05-25 The Penn State Research Foundation Gallotanin et ellagitanin en tant que regulateurs de la liberation de cytokines
JP3694733B2 (ja) * 2000-06-29 2005-09-14 独立行政法人農業・生物系特定産業技術研究機構 抗アレルギー剤
CA2424930A1 (fr) 2000-10-06 2003-04-04 Cmi-Centers For Medical Innovation Ag Procede de production d'extraits de phyllanthus
JP2004513092A (ja) * 2000-10-06 2004-04-30 シーエムアイ−センターズ・フォー・メディカル・イノヴェーション・アクチェンゲゼルシャフト ヌクレオシド性阻害剤耐性レトロウイルス又は非ヌクレオシド性阻害剤耐性レトロウイルスに付随した疾患の予防及び／又は治療のためのＰｈｙｌｌａｎｔｈｕｓ由来の化合物
DE10120627A1 (de) 2001-04-26 2002-10-31 Cmi Ag Verwendung von Phyllanthusbestandteilen zur Behandlung oder Prophylaxe von Infekten durch Hepatitis B-Viren
EP2116253A1 (fr) * 2008-05-07 2009-11-11 Phytrix JV, LLC Nouvel extrait de Phyllanthus
CN102301462A (zh) * 2009-02-12 2011-12-28 株式会社爱德万测试 半导体晶片测试装置
JP5653034B2 (ja) * 2009-12-18 2015-01-14 株式会社 伊藤園 抗ウイルス剤
WO2011085454A1 (fr) * 2010-01-18 2011-07-21 Katholieke Universiteit Leuven K.U.Leuven R&D Composés de benzènes et de saccharides se liant à gp120
CN102329342A (zh) * 2011-05-31 2012-01-25 苏州派腾生物医药科技有限公司 一种杜英素的制备方法
CN103749490B (zh) * 2014-01-08 2015-04-22 杨凌农科大无公害农药研究服务中心 一种抗植物病毒剂及其制备方法
CN104003999B (zh) * 2014-05-14 2016-01-13 中国科学院华南植物园 一种制备cinnamtannin B1的方法
CN106074668B (zh) * 2016-08-03 2019-09-27 黑龙江中医药大学 用于神经退行性疾病或神经再生的中药制剂
WO2021262799A1 (fr) * 2020-06-23 2021-12-30 Flagship Pioneering, Inc. Composés antiviraux et leurs procédés d'utilisation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7288273B1 (en) 2000-11-17 2007-10-30 The Penn State Research Foundation Gallotannins and ellagitannins as regulators of cytokine release

Also Published As

Publication number Publication date
WO1990004968A1 (fr) 1990-05-17

Similar Documents

Publication Publication Date Title
CA2001898A1 (fr) Inhibition de retrovirus humains
Ogata et al. HIV-1 reverse transcriptase inhibitor from Phyllanthus niruri
Nishizawa et al. Anti-AIDS agents, 1. Isolation and characterization of four new tetragalloylquinic acids as a new class of HIV reverse transcriptase inhibitors from tannic acid
Yu et al. Recent progress in the development of coumarin derivatives as potent anti‐HIV agents
Nonaka et al. Anti-AIDS agents, 2: inhibitory effect of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells
US5679684A (en) Hydroxyalkylammonium-pyrimidines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
CA2268703C (fr) Nucleosides a base de .beta.-d dioxolane sous forme d'enantiomere pur, manifestant une activite selective contre le virus de l'hepatite b
HIRABAYASHI et al. Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro
US5159069A (en) Sulfated tannins and their salts
EP0426785B1 (fr) Compositions et procedes de traitement d'infections virales
EP0476066A1 (fr) Composition anti-virale de 3'-azido-2',3'-didesoxy-5-methylcytidine.
US5079239A (en) Sterol disulfates and methods of use
US5654432A (en) Process of preparing michellamine compounds
EP0297547A2 (fr) Emploi de tannates hydrolysables pour le traitement et la prophylaxie du SIDA
AU6099194A (en) Antiviral naphthoquinone compounds, compositions and uses thereof
Samoylenko et al. Bioactive (+)-manzamine A and (+)-8-hydroxymanzamine A tertiary bases and salts from Acanthostrongylophora ingens and their preparations
CA2064772A1 (fr) Compositions antivirales contenant des derives de sulfoquinovosyl glycerol et leurs analogues et methodes pour leur utilisation
US4831053A (en) Composition for prophylaxis and therapy of hepatitis
AU1747695A (en) Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof
JPH085862B2 (ja) 新規なアコニチン系化合物およびそれらを有効成分とする鎮痛・抗炎症剤
US5077279A (en) 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
WO1996041800A1 (fr) Isolement de l'isoflavanone naturelle et quelques emplois cliniques de cette substance
Lee et al. Tannins and Related Compounds as Anti-HIV Agents 1
US5026732A (en) Use of avarone for the control of AIDS and ARC
WO2003070159A2 (fr) Nouveaux composes de coumarine et de chromene et leurs procedes de preparation et d'utilisation pour traiter ou prevenir des infections virales

Legal Events

Date Code Title Description
FZDE Dead